Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.

Authors:
Bellur S Prabhakar
Bellur S Prabhakar
University of Illinois at Chicago
Chicago, Illinois | United States

J Surg Res 2019 01 17;233:57-64. Epub 2018 Aug 17.

Division of Surgical Oncology, Department of Surgery, University of Illinois at Chicago, Chicago, Illinois. Electronic address:

Background: Colorectal cancer remains a leading cause of cancer-related mortality worldwide. Metastases to the liver are often present at initial presentation and will form in most patients during their course of disease. We have previously demonstrated that enhanced trafficking and activation of tumor-infiltrating lymphocytes in colorectal liver metastases (CRLM) may improve antitumor immune responses. Thus, development of novel mechanisms to increase lymphocyte infiltration and activation are needed to improve patient outcomes.

Methods: CT26 murine colorectal cancer cells were treated with physiologic levels of the potent inducer of immunogenic cell death mitoxantrone (MTX). An in situ vaccine was created with treated cells in an established model of CRLM. Cells were evaluated by flow cytometry for cell cycle evaluation and calreticulin expression. Splenic and tumor-infiltrating lymphocytes were isolated for phenotypic studies.

Results: MTX-treatment of colon cancer cells resulted in a sub-G1 peak, inhibition of G1 cell cycle progression, and increased G2/M cell fractions while simultaneously increasing dynamic exposure of calreticulin on the cell surface (P < 0.05). Vaccination with MTX-treated cells resulted in significant decreases in CRLM formation associated with increased tumor-infiltrating leukocytes that displayed increased expression of the T cell surface activation marker CD69.

Conclusions: Vaccination with MTX-treated primary colon cancer cells enhances tumor-infiltrating lymphocytes and clinical responses in CRLM.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2018.07.068DOI Listing
January 2019
2 Reads
1.936 Impact Factor

Publication Analysis

Top Keywords

cancer cells
12
tumor-infiltrating lymphocytes
12
colorectal cancer
8
colon cancer
8
liver metastases
8
colorectal liver
8
cell cycle
8
cells
5
cell
5
cells treated
4
improve patient
4
cells sub-g1
4
treated physiologic
4
needed improve
4
murine colorectal
4
patient outcomesmethods
4
activation needed
4
outcomesmethods ct26
4
ct26 murine
4
mtx-treatment colon
4

Similar Publications